Rachelle Schneiter
Psychiatric/Mental Health · Warren, OHNPI 1427481910
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $10,588 of the $15,161 with a category attached, or 69.8%. AbbVie accounts for 84.7% of it on its own, with 14 other manufacturers making up the rest. Reporting peaked in 2023 at $6,727 and has fallen 87.6% since, to $832 in 2025. Among psychiatric/mental health clinicians in OH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 183 payments — averaging $82.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$13K
- Otsuka America Pharmaceutical, Inc.$597
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$516
- Neurocrine Biosciences, Inc.$246
- Lundbeck LLC$194
- Alkermes, Inc.$163
- plus $603 from 9 others
What the payments were for
- Speaking & faculty fees$10,58870%
- Travel & lodging$1,1277%
- Food & beverage$3,40022%
- Education$470%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 70 | $12,842 |
| Otsuka America Pharmaceutical, Inc. | 29 | $597 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 24 | $516 |
| Neurocrine Biosciences, Inc. | 13 | $246 |
| Lundbeck LLC | 13 | $194 |
| Alkermes, Inc. | 6 | $163 |
| Vanda Pharmaceuticals Inc. | 7 | $146 |
| E.r. Squibb & Sons, L.L.C. | 6 | $110 |
| Sunovion Pharmaceuticals Inc. | 1 | $102 |
| Axsome Therapeutics, Inc. | 4 | $72 |
| Supernus Pharmaceuticals, Inc. | 3 | $52 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $44 |
| Johnson & Johnson | 2 | $39 |
| Sage Therapeutics, LLC | 1 | $25 |
| Validus Pharmaceuticals LLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$15,161 in reported general payments places this provider in the 95th percentile of 1,808 psychiatric/mental health providers in Ohio.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| CaplytaLumateperone Tosylate | 11 | $18,065 |
| Lurasidone Hcl | 25 | $3,498 |
| Bupropion XlBupropion Hcl | 14 | $312 |
| Escitalopram Oxalate | 27 | $251 |
| Hydroxyzine Pamoate | 15 | $211 |
| Lamotrigine | 24 | $145 |
| Duloxetine Hcl | 17 | $130 |
| Topiramate | 18 | $124 |
| Trazodone Hcl | 22 | $79 |
| Lorazepam | 14 | $22 |
| Sertraline Hcl | 11 | $19 |
| Fluoxetine Hcl | 13 | $18 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta | $516 | $18,06511 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,808 psychiatric/mental health providers in Ohio.
Other psychiatric/mental health in Warren
- Mary HallWarren$195K
- Zachary AldridgeWarren$44K
- Crystal TravisJackson$333K
- Kristina RoweIronton$253K
- Patricia SparksPortsmouth$210K
- Kassandra KornbauCanfield$170K
- Steven MatesDayton$121K
- Robert ParsonsYoungstown$119K
- Chriscia BaneChillicothe$115K
- Rachael McLaughlinMaple Heights$114K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.